Back Stocks profile

Stock analysis tool for investors

Shree Ganesh Bio-Tech (India) Ltd.

NSE: SHREEGANES | BSE:539470

₹1.30 -0.09 (-6.47%) 1D

Pharmaceuticals & Biotechnology

Open an Account with Bigul in 5 minutes

Performance

Today’s low

1.30

Today’s High

1.40

52W low

0.70

52W High

1.90

Open Price

1.40

Prev. Close

1.1300

Volume

6934216.00

Value

9014480.80

Fundamentals

Market Cap

51.80

Price to Earnings

60.60

Price to Book Value

0.80

Dividend Yield

0.00

PE to Growth

-0.90

Op Revenue TTM

20.28

Net Profit TTM

0.85

Cash From Operating Activity

10.16

Return on Equity %

0.98

EMA & SMA

Bullish Moving Averages

16

Bearish Moving Averages

0

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

05 Jul, 2024

69.3

Week

74

Month

71.5

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

1.35

PIVOT

First Resistance

1.43

Second Resistance

1.47

Third Resistance

1.55

First Support

1.31

Second Support

1.23

Third Support

1.19

Relative Strength Index

77.92

Money Flow Index

72.67

MACD

0.02

MACD Signal

0

Average True Range

0.04

Average Directional Index

23.39

Rate of Change (21)

27.52

Rate of Change (125)

-10.32

Commodity Channel Index

478.9

Williams %R

BETA

1 Month

-0.64

3 Month

0.27

1 Year

0.54

3 Year

0.42

PRICE CHANGE ANALYSIS

13.04%

1 Week

Low

High

1.14

1.44

11.11%

1 Month

Low

High

1.09

1.44

-2.99%

3 Months

Low

High

1.07

1.44

-15.58%

6 Months

Low

High

1.05

1.59

21.5%

1 Year

Low

High

0.7

1.89

Bigul
30 May 2024

Shree Ganesh Biotech (India) Ltd - 539470 - Disclosure Under Regulation 32(1) Of SEBI (LODR) Regulations, 2015

Disclosure under Regulation 32(1) of SEBI (LODR) Regulations, 2015
Bigul
30 May 2024

Shree Ganesh Biotech (India) Ltd - 539470 - Submission Of Audited Financial Results March 31, 2024

Audited Financial Results for the year ended on 31st March, 2024
Bigul
22 May 2024

Shree Ganesh Biotech (India) Ltd - 539470 - Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.

Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company will be held on Thursday 30th May 2024 at registered office of the company inter alia, to consider following business. 1. Approve and take on record the Audited Standalone Financial Results of the Company for the quarter and year ended on 3pt March 2024. 2. Any other matter which the Board may think fit. Please take the above intimation in your records. Thanking You.
See all News

FAQs

The latest market price of Shree Ganesh Bio-Tech (India) Ltd. on NSE was Rs. 1.30 as of today.

The opening share price of Shree Ganesh Bio-Tech (India) Ltd. was Rs. 1.40 as of today.

The 52-week high share price of Shree Ganesh Bio-Tech (India) Ltd. was Rs. 1.90.

The 52 week low share price of Shree Ganesh Bio-Tech (India) Ltd. was Rs. 0.70.

Please find Corporate actions section for more details.

The PE ratio of Shree Ganesh Bio-Tech (India) Ltd. is -0.90. Please refer to the Fundamentals section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please find Corporate actions section for more details.

The latest bonus issue declared by Shree Ganesh Bio-Tech (India) Ltd. was as of 2022-04-27. The bonus ratio declared in this issue was 1:1. Please refer to the Corporate Actions section for further details.

The latest split issue declared by Shree Ganesh Bio-Tech (India) Ltd. was as of 2022-02-10. The split ratio declared in this issue was 10:1. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Shree Ganesh Bio-Tech (India) Ltd..

Close

Let's Open Free Demat Account